• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Vitamin extends life in yeast


  • Please log in to reply
4 replies to this topic

#1 Matt

  • Guest
  • 2,862 posts
  • 149
  • Location:United Kingdom
  • NO

Posted 03 May 2007 - 08:05 PM


Vitamin extends life in yeast, Dartmouth Medical School researchers find
http://www.eurekaler...s-vel042607.php

Hanover, NH--Imagine taking a vitamin for longevity! Not yet, but a Dartmouth discovery that a cousin of niacin prolongs lifespan in yeast brings the tantalizing possibility a step closer.

The research, reported in the May 4 issue of Cell, shows how a new vitamin extends lifespan in yeast cells, much like calorie restriction does in animals. It could pave the way for developing supplements to benefit humans.

Radical calorie reduction can extend life. Dieting or fasting mice live longer and lowering the glucose that yeast grow on extends their lifespan, according to Dr. Charles Brenner, associate professor of genetics and of biochemistry, who led the research.

“If we could do this in humans -- give people a drug or vitamin that would mimic effects of calorie restriction without having to skip lunch -- we would be able to provide some of the benefits of calorie restriction, which are pretty striking in model organisms,” said Brenner, also a member of the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center.

Many benefits, explains Brenner, depend on a family of proteins called sirtuins—dubbed anti-aging gene products for the important roles they play in longevity and energy expenditure, although the precise mechanisms are still being figured out.

His team found that providing a newly discovered vitamin activates the yeast anti-aging gene product Sir2, which resembles sirtuins found in humans. The new work builds on Brenner’s prior discovery of the vitamin, termed NR (nicotinamide riboside), a natural product found in milk. Like the B3 vitamin, niacin, NR is a precursor to a versatile cellular factor that is vital for all life.

The factor, called NAD, short for nicotinamide adenine dinucleotide, is elevated by calorie restriction. So the researchers set out to develop an intervention to elevate NAD, using yeast cells, whose genes are easy to manipulate. “It’s surprising that no one was be able to elevate NAD with a small molecule before,” Brenner said.

The team discovered two pathways that allow yeast to raise NAD levels with NR, improve their control of gene expression and live longer in the presence of high glucose. One of the pathways is new; the other was previously identified by Brenner’s lab.

At the molecular level, elevating NAD to turn on Sir2 actually enables the yeast to silence genes that are not supposed to be expressed. In any organism, not all genes are on at once; in yeast, there are sets of genes that Sir2 normally represses.

”We showed that that we could improve Sir2-dependent gene silencing with NR and increase the longevity of yeast grown in high glucose conditions,” Brenner said.

To test for Sir2 gene repression, the investigators found conditions in which wild-type cells can’t accomplish normal gene silencing. Then, when they take up NR through one of the pathways Brenner’s team discovered, Sir2 gene silencing is restored, and yeast are rejuvenated. Yeast cells formerly capable of dividing 13 times, divided over 23 times when given NR.

Deletion of either pathway makes NR only half as effective as it is when both pathways are intact. So yeast cells seem to use both pathways equally well to lengthen their lifespan. The first NR pathway, described in 2004, consists of a gene common to yeast and humans. In fact, that gene is activated in damaged neurons in order to allow NR to protect against loss of axons. The second NR pathway involves three yeast genes, two of which are found in humans.

Granted that the human anti-aging apparatus is more complex, but animal studies indicate potential. Perhaps the best known sirtuin activator is the red wine compound resveratrol. Overfed mice on high dose resveratrol have healthier livers, better endurance and possibly longer lifespan. While resveratrol and NR work through different mechanisms to increase sirtuin activity, Brenner said, “the two compounds could be complementary or synergistic.”

More testing remains for NR in humans, but Brenner foresees intriguing possibilities. “As a natural product found in milk, we expect the compound to be much safer than most drugs, and to be a more specific remedy than most vitamins.”

Though aging itself is not a disease, Brenner anticipates applications in conditions associated with aging including neurodegenerative diseases, metabolic syndrome, and elevating good cholesterol. There are also indications that NR could be a treatment for one type of Candida infection.

#2 edward

  • Guest
  • 1,404 posts
  • 23
  • Location:Southeast USA

Posted 05 May 2007 - 03:44 AM

Nicotinamide/niacinamide inhibits the SIRTs, according to Sinclair quite profoundly, I'm still waiting for this to be all figured out but from my research it appears that nicotinamide/niacinamide is pro aging and I have eliminated it from my supplements.

sponsored ad

  • Advert
Click HERE to rent this advertising spot for SUPPLEMENTS (in thread) to support LongeCity (this will replace the google ad above).

#3

  • Lurker
  • 0

Posted 05 May 2007 - 03:12 PM

Nicotinamide/niacinamide inhibits the SIRTs, according to Sinclair quite profoundly, I'm still waiting for this to be all figured out but from my research it appears that nicotinamide/niacinamide is pro aging and I have eliminated it from my supplements.


http://www.sirtrisph...-1/Default.aspx

Charles Brenner, Ph.D.

Dr. Brenner is Associate Professor of Genetics and of Biochemistry, Dartmouth Medical School, and Director of the Cancer Mechanisms Program at Norris Cotton Cancer Center. Dr. Brenner's laboratory uses yeast genetics, enzymology and X-ray crystallography to dissect cellular pathways that are conserved between yeast and humans. His laboratory discovered the eukaryotic nicotinamide riboside kinase pathway to NAD in 2004. A former March of Dimes Basil O'Connor Scholar, Burroughs Wellcome Foundation New Investigator and Beckman Young Investigator, Brenner earned his PhD at Stanford University and conducted post-doctoral work at Brandeis University.


I would ask them.

Or AOR who sells Benagene.

benaGene has been designed to modify metabolism to mimic calorie restricted conditions at the cellular level--without the usual reduction in calorie content.  It does this by providing a balanced blend of excess citric acid cycle intermediates (already found within every cell of the human body) to modify the NAD+/NADH ratio.  The NAD+/NADH ratio is increased by using a biological diode interaction with the mitochondria.  The increased ratio (when held for a minimum of at least a 2.5 week period) acts as a switching sensor that causes the cells to produce a series of beneficial proteins from DNA genes that are typically silenced in normal metabolism.

benaGene works on several levels to reduce the effects of aging:

The proteins expressed by the genes are "turned back" to a younger profile. This same profile is seen by calorie restricted animals, and increases lifespan and heath span by 20 to 40% in laboratory tests.  See More.
Blood glucose levels are reduced.  This results in lower Advanced Glycation End-products (AGEs) because there are lower glucose levels overall to react with the proteins. See More. 
Weight levels are dropped, resulting in lower risk factors for diabetes, heart disease and other weight related illness. See More.
benaGene acts as a powerful anti-oxidant to reduce cellular damage from free radicals.
benaGene increases the rate of gluconeogenesis, which increases protein turn-over in the cells.  Regeneration of cellular proteins reduces damaged cross-link protein accumulation.
Finally, benaGene promotes an increase in DNA repair
As a consequence of these changes, the results are revolutionary:

Life Extension & Increased Heath Span
C57Bl/6 mice live 25% longer on a benaGene supplemented diet
mice supplemented with benaGene show less age related disease including inflammation, curvature of the spine, graying of fur
The increase in remaining lifespan (from the date benaGene supplementation was started) is 40% in mice
Drosophila melanogaster (fruit flys) live 20% longer on a benaGene supplemented diet
Caenorhabditis elegans (worms) live 36% longer with benaGene added to the agar mix
Weight Management
C57Bl/6 mice given benaGene gain less weight than control groups when fed an unrestricted diet
Genomic Changes
Proteins upregulated and down-regulated mimic a calorie restricted profile (98.1% directional correlation in mouse liver tissue) after 21 weeks of use
Glucose Reduction
Clinical human trials on benaGene ingredients show an average reduction in fasting glucose levels of 25% in Type I and Type II diabetics
Glucose uptake on both diabetic and non-diabetic humans is increased at the cellular level



#4 rwoodin

  • Guest
  • 67 posts
  • 1
  • Location:North Carolina, USA
  • NO

Posted 06 May 2007 - 01:02 AM

I thought that there was a whole lot of discussion on the 500 Club thread a that Niacinamide/Nicotinamide was supposed to be the 'anti-resveratrol'. Now this study is claiming that it is life extending? I dont get it. Could someone help to clarify this please. Is it that these results regarding Nicotinimide and Resveratrol are completely contradicting each other?


from 500 club thread - late March 2007...


QUOTE 
Anyone have any clarity on the Niacinamide/Niacin inhibition of SIRT1. I could research it but if anyone has a quick explanation let me know.

The story seems to be that niacinamide is the anti-resveratrol, so to speak. Niacin would be the preferred form in that regard. Here's a paper from Sinclair's group.

QUOTE 
J Biol Chem. 2002 Nov 22;277(47):45099-107. Epub 2002 Sep 23.  FREE TEXT, Yow!!
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA.
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.

PMID: 12297502



sponsored ad

  • Advert
Click HERE to rent this advertising spot for SUPPLEMENTS (in thread) to support LongeCity (this will replace the google ad above).

#5 proteomist

  • Guest
  • 177 posts
  • 1

Posted 06 May 2007 - 02:51 AM

They gave nicotinamide riboside (NR), which is converted to NAD+, which is a cofactor for Sir2 activity. The reaction catalyzed by Sir2 yields nicotinamide with the ribose removed. Whereas NAD+ and by extension its precursor NR are pro-Sir2 activity, nicotinamide is a reaction product that can actually compete with the forward reaction to drive it backwards.

Thus, they are two rather different species. Still, the limiting activity as I understand it is reconversion of nicotinamide to NAD+. I would think that giving extra NR would ultimately give a steady-state elevation of nicotinamide levels, but maybe not.

I'm somewhat surprised nobody here has yet commented on the fact that isonicotinamide, a nicotinamide analog, can sit in Sir2 and block nicotinamide from interfering with Sir2 activity. Yeast studies show it can agonize Sir2 activity levels several fold, if I remember correctly.




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users